期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

PPARs激动剂在心脑血管疾病中的研究进展 被引量：6

Research progress of PPARs agonists on cardiovascular and cerebrovascular diseases
原文传递
导出
摘要 PPARs是一类由配体激活的转录因子,属于Ⅱ型核受体超家族成员。PPARs被激活后,能够改善胰岛素抵抗(IR)、纠正脂质代谢紊乱、逆转心肌肥厚、抑制血管平滑肌细胞(VSMCs)和内皮细胞的增殖与迁移,从而改善心脑血管的病理性重构,并具有降压效应。因此,PPARs激动剂的研究在心脑血管疾病的防治中具有重要的理论意义和临床应用价值。本文对近几年的PPARs激动剂进行综述。 PPARs are a class of ligand-activated transcription factors belonging to the nuclear receptor super- family type Ⅱ members. PPARs agonists can improve insulin resistance （IR）, correct lipid metabolism disor- ders, reverse cardiac hypertrophy,inhibit VSMCs（ vascular smooth muscle cells）and endothelial cell＇s prolife- ration and migration, and further improve cardiovascular pathological remodeling with antihypertensive effect by activating PPARs. PPARs agonists have important theoretical significance and clinical applications in treatment of cardiovascular and cerebrovascular diseases. This review summarized the progress on PPARs agonists in recent years.
作者 曾正英 廖高鸿 吕雅斐 陈国良
机构地区 沈阳药科大学基于靶点的药物设计与研究教育部重点实验室
出处 《中国药物化学杂志》 CAS CSCD 2014年第2期147-156,共10页 Chinese Journal of Medicinal Chemistry
关键词 过氧化物酶体增殖物激活受体 激动剂 心脑血管 peroxisome proliferator-activated receptor agonists cardiovascular
分类号 R743 [医药卫生—神经病学与精神病学]
  • 相关文献

参考文献6

二级参考文献54

  • 1Delerive P,Martin NF, Chinetti G,et al. Peroxisome proliferator-activated receptor activator inhibit thrombin-induced endothelin-1 production in human vascular endothelial cells by inhibiting the activator protein-1 signaling pathway[J]. Circ Res, 1999,85:394 -402.
  • 2Law RE, Goetze S, Xi XP,et al. Expression and function of peroxisome proliferator activated receptor gammar in rat and human vascular smooth muscle cells [J]. Circulation, 2000, 101:1311 - 1318.
  • 3Diep QN, Schiffrin EL. Increased expression of peroxisome proliferator-activated receptor-α and - γ in blood vessels of spontaneously hypertensive rats[ J]. Hypertension, 2001,38:249 - 254.
  • 4Ryan M J, Didion SP, Mathur SP, et al. PPAR γ agonists roglitazone improves vascular function and lowers blood pressure in hypertensive transgenic mice[ J]. Hypertension, 2004, 43 (3) :661 - 666.
  • 5Fullert S,Schneider F,Haak E ,et al. Effects of pioglitazone in nondiabetic patients with arterial hypertension: a double - blind, placebo-controlled study[ J]. J clin Endocrinol Metab, 2002, 87 ( 12 ):5503 - 5506.
  • 6Guerre- Millo M et al. Peroxisome proliferator - activated receptor alpha activators improve insulin sensitivity and reduce adiposity.J Biol Chem 2000;275:16638- 16642.
  • 7Staels B, Koenig W, Habib A, et al. Activation of human aortic smooth - muscle cells is inhibited by PPAR - α but not by PPAR - γactivators. Nature 1998 ;393: 790 - 793.
  • 8Marx N, Duez H, Fruchart J. C, et al. Peroxisome proliferator -activated receptors and atherogenesis regulators of gene expression in vascular cells, Circ Res 2004;94:1168- 1179.
  • 9Walus B. I, Sieradzki J, Rostworowski W, et al. Effects of comicronised fenofibrate on lipid and insulin sensitivity in patients with polymetabolic syndrome X. Eur J of Clin Invest 2000; 30: 871 - 878.
  • 10Ansquer JC, Foucher C, Rattier S, et al. Fenofibrate reduces progression to microalbuminuria over 3 years in a placebo- controlled study in type 2 diabetes: results from the Diabetes Atherosclerosis Intervention Study(DAIS). Am J Kidney Dis 2005 ;45:485 - 493.

共引文献35

同被引文献57

引证文献6

二级引证文献39

中国药物化学杂志
2014年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部